20911 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
SYNTHETIC PEPTIDE COMPOUNDS AND METHODS OF USE
#2Macrophage depletion and vesicular stomatitis virus for treatment of cancer
#3Combination treatment for atopic dermatitis
#4METHOD OF TREATMENT OF HIV INFECTION WITH VACCINE
#5SECRETED RNA THERAPEUTICS FOR NUCLEAR DELIVERY
#6PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#7CPG AMPHIPHILES AND USES THEREOF
#8LIPID POLYSACCHARIDE AMINO ACID NANOPARTICLES AND USE THEREOF
#9OXR1 GENE THERAPY
#10COMBINATION THERAPIES
#11RNA RECOGNITION COMPLEX AND USES THEREOF
#12THERAPEUTICS DIRECTED AGAINST CORONAVIRUS
#13HUMANIZED RECOMBINANT VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN (hrVCP) FOR PROTECTION OF COGNITIVE FUNCTION
#14PSEUDOTYPED LENTIVIRAL VECTORS
#15METHODS FOR CASCADE AMPLIFICATIONS OF THERAPEUTIC PAYLOADS (CATP) & COMPOSITIONS FOR CANCER IMMUNOTHERAPIES AND GENE THERAPY
#16EXOSOMES EXPRESSING RSVF AND USE THEREOF
#17METHODS OF TREATING FRIEDREICH'S ATAXIA
#18RETROVIRAL VECTORS
#19CPG AMPHIPHILES AND USES THEREOF
#20NEW METHOD FOR IDENTIFYING HERV-DERIVED EPITOPES
#21GLYCAN STRANDS AND OLIGOSACCHARIDES DERIVED FROM STREPTOCOCCUS BACTERIA
#22PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#23SMALL EXTRACELLULAR VESICLES EXPRESSING A DOMINANT NEGATIVE AMPK ALPHA 1 MUTANT FOR USE IN THE TREATMENT OF OBESITY
#24Antigenic Epstein Barr Virus Polypeptides
#25USE OF PBX1 IN PROMOTING HAIR GROWTH
#26TDP-43 Interference Peptides, Methods, and Uses Thereof
#27USE OF LYSIN TO RESTORE/AUGMENT ANTIBACTERIAL ACTIVITY IN THE PRESENCE OF PULMONARY SURFACTANT OF ANTIBIOTICS INHIBITED THEREBY
#28VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#29NUCLEIC ACID COMPOSITIONS AND USES THEREOF
#30Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines
#31POLYPEPTIDE BASED ON RECEPTOR-INTERACTING PROTEIN KINASE-3 METHYLATION MODIFICATION AND APPLICATION THEREOF IN CELL NECROPTOSIS-RELATED DISEASES
#32Compositions and Methods for Treatment and Prevention of Misfolded Proteins
#33Method for Manufacturing Biosensor
#34PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#35METHODS AND COMPOSITIONS FOR HIGH-POTENCY POLYPEPTIDE-BASED PROTEIN INHIBITION
#36NOVEL DRUGGABLE REGIONS IN THE HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B POLYPEPTIDE AND METHODS OF USE THEREOF
#37DEVICE AND METHODS FOR ACNE THERAPEUTICS: ANTIBACTERIAL BACTERIOPHAGES AND ENGINEERED LYSINS
#38ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF
#39THERAPEUTICS DIRECTED AGAINST CORONAVIRUS
#40Conformationally Specific Viral Immunogens
#41SMALL HYDROPHOBIC PROTEIN DRUG CONJUGATES AND USES THEREOF
#42METHODS OF TREATING OCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT
#43METHODS OF TREATING ALZHEIMERS DISEASE
#44AMURINS LYSINS, AND LYSIN-ANTIMICROBIAL PEPTIDE (AMP) CONSTRUCTS ACTIVE AGAINST GRAM-NEGATIVE BACTERIA
#45PEPTIDIC POSITIVE ALLOSTERIC MODULATORS TARGETING TRPV1
#46METHOD FOR ACTIVATING T CELLS FOR CANCER TREATMENT
#47COMPOSITIONS AND METHODS FOR DOMINANT ANTIVIRAL THERAPY
#48LIPOPEPTIDES FOR USE IN TREATING LIVER DISEASES AND CARDIOVASCULAR DISEASES
#49GENE THERAPIES FOR LYSOSOMAL DISORDERS
#50METHODS OF MANUFACTURING GENETICALLY-MODIFIED LYMPHOCYTES
#51USE OF AAV-EXPRESSED M013 PROTEIN AS AN ANTI-INFLAMMATORY THERAPEUTIC
#52PEPTIDES ENDOWED WITH ANGIOGENIC ACTIVITY
#53COMPOSITION FOR IMMUNE TOLERANCE INDUCTION AND USE IN GENE THERAPY
#54Immunomodulators Targeting MORC3 for Interferon Induction
#55Synthetic peptide compounds and methods of use
#56Antigenic epstein barr virus polypeptides
#57TREATING DIABETES
#58LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
#59COMPOSITIONS AND METHODS FOR TARGETING THE INTERACTION OF HOST MYO5B+D AND CORONAVIRUS M PROTEINS
#60COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISEASES
#61COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME
#62Compositions and methods for inhibiting the activity of LAR family phosphatases
#63METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTION
#64PHAGE AND TRANSDUCTION PARTICLES
#65Bacterial Vehicle for Engineering of Non-Phagocytic Immune Cells
#66HIGHLY-NETWORKED CORONAVIRUS IMMUNOGEN COMPOSITION
#67ARTIFICIAL ALPHAVIRUS-DERIVED RNA REPLICON EXPRESSION SYSTEMS
#68METHODS FOR TREATING AND PREVENTING CYTOMEGALOVIRUS INFECTION
#69Coronavirus T Cell Epitopes and Uses Thereof
#70Therapeutics directed against coronavirus
#71Antigenic Epstein Barr virus polypeptides
#72THERAPEUTIC TARGETING OF PHOSPHATE DYSREGULATION IN CANCER VIA THE XPR1:KIDINS220 PROTEIN COMPLEX
#73METHODS AND COMPOSITIONS FOR UPREGULATING RNA INTERFERENCE AND ENHANCING GENE SILENCING
#74COMPOSITIONS USEFUL IN TREATMENT OF KRABBE DISEASE
#75MESENCHYMAL STEM CELLS THAT ENABLE TUMOR TARGETING IMPROVEMENT AND VIRUS MASS-PRODUCTION
#76METHODS FOR PREVENTING INDUCTION OF IMMUNE RESPONSES TO THE TRANSDUCED CELLS EXPRESSING A TRANSGENE PRODUCT AFTER OCULAR GENE THERAPY
#77SCAFFOLDED HIV-1 VACCINE IMMUNOGENS
#78FcRn-targeted therapeutics for the treatment of antibody-mediated autoimmune and albumin-mediated disease
#79METHODS AND COMPOSITIONS RELATED TO HIV-1 NANOPARTICLE VACCINES WITH IMPROVED PROPERTIES
#80PEPTIDES HAVING SPECIFICITY FOR THE LUNGS
#81Compositions and methods for dengue virus chimeric constructions in vaccines
#82PEPTIDE FOR SUPPRESSING CORONAVIRUS AND USE THEREOF
#83LNP COMPOSITIONS COMPRISING AN MRNA THERAPEUTIC AND AN EFFECTOR MOLECULE
#84STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA
#85EPSTEIN-BARR VIRUS ANTIBODIES AND USES THEREOF
#86PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#87Crystal form, preparation method, and application of 4'-substituted nucleoside
#88Use of Immune Suppressive Domains as Medicaments
#89LYSIN POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA
#90POLYPEPTIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#91ANTIMICROBIAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE AND ACID-FAST BACTERIA
#92COMBINATION THERAPY WITH ANTI-PVRIG ANTIBODIES FORMULATIONS AND ANTI-PD-1 ANTIBODIES
#93PTD-SMAD7 THERAPEUTICS
#94COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION WITH A THERAPEUTIC INTERFERING PARTICLE
#95Peptides for the treatment of COVID-19
#96Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
#97ADENO-ASSOCIATED VIRUSES AND METHODS AND MATERIALS FOR MAKING AND USING ADENO-ASSOCIATED VIRUSES
#98GALECTIN-TARGETING IMMUNOTHERAPY
#99HUMAN ANTIBODIES AND ANTIBODY-DRUG CONJUGATES AGAINST CD74
#100ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I LIKE PROTEIN (OMCP) FOR TREATMENT OF AUTOIMMUNE DISEASE
#101PHARMACEUTICAL COMPOSITION COMPRISING VACCINIA VIRUS AND HYDROXYUREA AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER
#102Artificial alphavirus-derived RNA replicon expression systems
#103AD36E4ORF1: A THERAPEUTIC TREATMENT FOR ALZHEIMER'S DISEASE
#104RETROVIRAL VECTORS
#105NOVEL ANTIVIRAL THERAPIES
#106Modified AAV Capsid Proteins for Treatment of Arthritic Disease
#107Antibacterial composition effective in treating gram negative bacterial infections and method for preparing the same
#108STABLE ALBUVIRTIDE COMPOSITIONS
#109Antimicrobial compositions and methods of use thereof
#110THERAPEUTICS DIRECTED AGAINST CORONAVIRUS
#111ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR
#112Combination treatment for atopic dermatitis
#113Genetically Engineered Cells and Uses Thereof
#114Chloride salt of TAT-NR2B9C
#115THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA
#116NEUTRALIZING VACCINES AGAINST HUMAN CORONAVIRUS
#117STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA
#118PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#119METHODS FOR PREPARING ALUMINUM PRECIPITATE COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES
#120APPLICATION OF 2,4,5-TRISUBSTITUTED 1,2,4-TRIAZOLONES IN ANTIVIRAL THERAPY
#121Fc Receptor-ACE2 Conjugates and Use Thereof
#122THERAPEUTIC NANOCONJUGATES AND USES THEREOF
#123STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA
#124Compositions and methods for dengue virus chimeric constructions in vaccines
#125OXR1 GENE THERAPY
#126COMBINATION THERAPY OF HBV AND HDV INFECTION
#127DUAL VECTOR FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS
#128FUSOSOME COMPOSITIONS FOR CNS DELIVERY
#129Method to treat Alzheimer's disease
#130NOVEL RECOMBINANT EXOSOME AND USE THEREOF
#131BACTERIOPHAGE-DERIVED RECOMBINANT PROTEIN HAVING ANTIMICROBIAL ACTIVITY AGAINST PATHOGENIC GRAM-NEGATIVE BACTERIA
#132HIV/SIV Nef fusion proteins for exosome targeted expression
#133Mineral coated microparticles for co-delivery of anti-inflammatory molecules with nucleic acids to improve gene delivery outcomes
#134ANTIMICROBIAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE BACTERIA
#135COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISRODERS
#136Conformationally-specific viral immunogens
#137Composition and use of Cas protein inhibitors
#138PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#139Methods for treatment of cancer using chikungunya-VSV chimeric virus
#140Endolysins active against bacteria, pharmaceutical compositions, and methods relating thereto
#141Poxvirus host range protein K3 as a positive selection marker for generation of recombinant poxviruses, a therapeutic target for poxvirus infection and a therapeutic agent for PKR related diseases
#142HIV antibody derivatives with dual antiviral and immunomodulatory activities from CD4 and GP41
#143T-CELL INDUCING VACCINE COMPOSITION COMBINATION AND USES THEREOF
#144VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER
#145Compositions and methods for inhibiting the activity of LAR family phosphatases
#146VACCINES WITH INTERLEUKIN-33 AS AN ADJUVANT
#147THERAPY OF ATHEROSCLEROSIS, PRIMARY BILIARY CIRRHOSIS AND NRLP3 INFLAMMASOME-ASSOCIATED DISEASE BY HTCP INHIBITORS
#148PEPTIDES HAVING SPECIFICITY FOR THE LUNGS
#149Glycan strands and oligosaccharides derived from bacteria
#150POLYPEPTIDE, DERIVATIVES THEREOF, AND APPLICATION THEREOF IN PREPARATION OF DRUGS HAVING RESISTANCE TO PULMONARY FIBROSIS
#151POROUS SILICON MATERIALS COMPRISING A METAL SILICATE FOR DELIVERY OF THERAPEUTIC AGENTS
#152Synthetic peptide compounds and methods of use
#153COMBINATION THERAPY USING A PEPTIDE
#154NANOSTRUCTURE WITH A NUCLEIC ACID SCAFFOLD AND VIRUS-BINDING PEPTIDE MOIETIES
#155AAV COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE
#156USE OF TAIL FIBER PROTEIN IN THE PREVENTION OF ACINETOBACTER BAUMANNII INFECTIONS
#157METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT
#158Recombinant host cell with heterologous nucleic acids encoding SHREK proteins
#159INHIBITION OF INNATE IMMUNE RESPONSE
#160Compositions and methods for treating diseases by inhibiting exosome release
#161Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
#162Hepatitis B virus-derived polypeptide and anti-viral use thereof
#163METHODS FOR TREATING FLAVIVIRUSES AND ZIKA INFECTIONS
#164Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof in human serum
#165PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#166CpG amphiphiles and uses thereof
#167Scaffolded HIV-1 Env GP140 trimer immunogen
#168COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL CORD INJURY
#169Antigenic Epstein Barr virus polypeptides
#170Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal
#171METHODS OF MANUFACTURING GENETICALLY-MODIFIED LYMPHOCYTES
#172Method for activating T cells for cancer treatment
#173COMPOSITIONS COMPRISING HIV ENVELOPES TO INDUCE HIV-1 ANTIBODIES
#174Antimicrobial compositions and methods of use thereof
#175Non-human papillomaviruses for gene delivery in vitro and in vivo
#176Chloride salt of TAT-NR2B9C
#177Lipopeptides for Use in Treating Liver Diseases and Cardiovascular Diseases
#178Lysin polypeptides active against Gram-negative bacteria
#179Aluminum compounds for use in therapeutics and vaccines
#180VIRAL VECTORS AND THEIR USE IN THERAPEUTIC METHODS
#181Therapeutic Drug for Non-Alcoholic Fatty Liver Disease
#182Gene therapies for lysosomal disorders
#183Compositions and methods for treating metabolic diseases
#184Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
#185FcRn-targeted therapeutics for the treatment of antibody-mediated autoimmune and albumin-mediated disease
#186KEY AMINO ACID SITES REGULATING NUCLEAR EXPORT OF NUCLEOPROTEIN IN INFLUENZA A AND B VIRUSES AND USE THEREOF AS ANTI-INFLUENZA VIRUS DRUG TARGETS
#187METHOD FOR THE TREATMENT OF CANCERS BY MEANS OF GENETIC NEUROENGINEERING
#188Method for activating T cells for cancer treatment
#189VIRAL FUSION PROTEIN TREATMENT FOR CCR8 MEDIATED DISEASES
#190Synthetic peptide compounds and methods of use
#191PHAGE AND TRANSDUCTION PARTICLES
#192COMPOSITIONS AND METHODS FOR TREATING MYELIN DISORDERS
#193Methods for treating depression and major depressive disorder
#194JNK Inhibitor Molecules For Treatment Of Various Diseases
#195Antibacterial compositions, methods of making and use thereof
#196REAGENTS FOR INDUCING AN IMMUNE RESPONSE
#197Mineral coated microparticles for co-delivery of anti-inflammatory molecules with nucleic acids to improve gene delivery outcomes
#198lysins for detection and treatment of gram positive bacteria
#199Therapy for subarachnoid hemorrhage and ischemia
#200Protein Kinase C-delta targeted therapy for treating radiation injury
#201Method for treating lung cancer
#202POLYPEPTIDE VACCINE
#203COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
#204Compositions and Methods for Dengue Virus Chimeric Constructs in Vaccines
#205Treating Animal Cancers Through Programmed Cancer Cell Death
#206Epstein-Barr virus antibodies and uses thereof
#207Microorganisms and methods for producing biologics and introducing biologics to sites
#208Compositions and methods for treating retinopathy
#209PTD-SMAD7 THERAPEUTICS
#210METHODS AND COMPOSITIONS COMPRISING VIRAL GENE THERAPY AND AN IMMUNE CHECKPOINT INHIBITOR FOR TREATMENT AND PREVENTION OF CANCER AND INFECTIOUS DISEASES
#211bacteriophage lysins for detection and treatment of gram positive bacteria
#212Combination treatment for atopic dermatitis
#213TUMOR-TARGETING BEAD VECTORS AND METHODS OF USING THE SAME
#214Peptide compounds to regulate the complement system
#215MALARIA VACCINE
#216Arginine-rich polypeptide compositions and methods of using same
#217Acinetobacter lysins
#218COMPOSITIONS AND METHODS FOR EXOSOME TARGETED EXPRESSION
#219Use of a HIV derived accessory protein for the reactivation of latent HIV
#220Method for preparing cells expressing Nef-fusion proteins associated with exosomes
#221CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS
#222Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
#223Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#224Prelyophilized, lyophilized and reconstituted formulations comprising TAT-NR2B9C with d-amino acids, histidine and trehalose
#225Method for cellular RNA expression
#226Synthetic peptide compounds and methods of use
#227GENE TRANSFER INTO AIRWAY EPITHELIAL STEM CELL BY USING LENTIVIRAL VECTOR PSEUDOTYPED WITH RNA VIRUS OR DNA VIRUS SPIKE PROTEIN
#228Chloride salt of TAT-NR2B9c
#229ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF
#230DNA, METHODS ETC
#231VSV/NDV hybrid viruses for oncolytic therapy of cancer
#232Lipopeptides for use in treating liver diseases and cardiovascular diseases
#233SIGNAL-SMART ONCOLYTIC VIRUSES IN TREATMENT OF HUMAN CANCERS
#234METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES
#235Compositions and methods for treating diseases by inhibiting exosome release
#236Antibacterial compositions, methods of making and use thereof
#237Scaffolded HIV-1 vaccine immunogens
#238METHODS FOR IDENTIFYING AND TREATING HEMOGLOBINOPATHIES
#239Conformationally Specific Viral Immunogens
#240Targeting of human glucocorticoid receptor beta in cancer
#241Method of preparing porcine circovirus type 2 capsid protein and pharmaceutical composition comprising same
#242Lysin polypeptides active against Gram-negative bacteria
#243Composition comprising bacteriophages for reducing, eliminating and/or preventing , and B
#244Methods and pharmaceutical compositions for the treatment of filovirus infections
#245TREATMENT OF CANCERS WITH IMMUNOSTIMULATORY HIV TAT DERIVATIVE POLYPEPTIDES
#246ORAL ANTI-INFLAMMATORY PEPTIDES TO TREAT EPILEPSY, SEIZURES AND CNS DISORDERS
#247Protein prostheses for mitochondrial diseases or conditions
#248Methods for inducing migration by dendritic cells and an immune response
#249Derivative Peptide Compounds and Methods of Use
#250Therapeutic peptides and vaccines
#251MATERIALS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS AND FOR INDUCTION OF ION SECRETION
#252Vaccines with interleukin-33 as an adjuvant
#253TELOMERE EXTENSION AND ANTI-INFLAMMATORY AGENTS FOR CELL REGENERATION
#254Fusion proteins comprising P3 of bacteriophage
#255BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF
#256PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES
#257Inhibition of innate immune response
#258Method of inducing an immune response by administering exosomes comprising Nef-fusion proteins
#259Compositions and methods for treating diseases by inhibiting exosome release
#260H7N2 INFLUENZA A VIRUS
#261Production of nucleic acid
#262Therapy of atherosclerosis, primary biliary cirrhosis and NRLP3 inflammasome-associated disease by HTCP inhibitors
#263Compositions and methods related to inhibition of respiratory syncytial virus entry
#264Anti-cancer vaccine combination
#265Peptide compounds to regulate the complement system
#266Compositions and methods for inhibiting the activity of LAR family phosphatases
#267COMBINATION THERAPY OF HBV AND HDV INFECTION
#268Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal
#269PEPTIDE INHIBITORS OF HAUSP DEUBIQUITINASE
#270Engineered endothelial cells expressing an ETS transcription factor
#271Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
#272Compositions and methods for treating diseases by inhibiting exosome release
#273Anti-tumor medicament based on adenovirus
#274Conformationally specific viral immunogens
#275Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#276Therapeutic compositions for neutralizing type I interferons, and methods of use
#277Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity
#278Stabilized single human CD4 domains and fusion proteins
#279Nanostructures comprising cobalt porphyrin-phospholipid conjugates and polyhistidine-tags
#280Methods and pharmaceutical compositions for the treatment of filovirus infections
#281COMPOSITION AND USES THEREOF
#282NOVEL RECOMBINANT EXOSOME AND USE THEREOF
#283Compositions and methods for exosome targeted expression
#284Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide
#285METHODS AND COMPOSITIONS FOR TREATING BRAIN DISEASES
#286Cell-permeable peptide system for treating diseases caused by glutamate excitotoxicity
#287Adenovirus AD36 E4ORF1 Protein For Prevention and Treatment of Non-Alcoholic Fatty Liver Disease
#288Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus
#289Compositions and methods related to viral vaccines
#290Fusion proteins comprising P3 of bacteriophage
#291AAV-Based Gene Therapy
#292Production of nucleic acid
#293bacteriophage lysins for detection and treatment of gram positive bacteria
#294Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines
#295Viral vectors and their use in therapeutic methods
#296Compositions and methods for dengue virus chimeric constructs in vaccines
#297Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells
#298Treatment of cancers with immunostimulatory HIV Tat derivative polypeptides
#299MODIFIED VP1-CAPSID PROTEIN OF PARVOVIRUS B19
#300Lysosome membrane protein 2 (LIMP-2) based peptides and related uses